Poster preview
ePoster
ELUCIDATING SYNGAP1 ISOFORM FUNCTIONS IN HUMAN NEURODEVELOPMENT USING CEREBRAL ORGANOIDS
Ivanna Kupryianchyk-Schultzand 5 co-authors
MDC BIMSB
FENS Forum 2026 (2026)
Barcelona, Spain
Board PS06-09PM-096
Presentation
Date TBA
Board: PS06-09PM-096
Event Information
Poster Board
PS06-09PM-096
Poster
View posterAbstract
SYNGAP1, encoding Ras/Rap GTPase activating protein, is a critical gene involved in synaptic signaling and neurodevelopment. Mutations in SYNGAP 1 are associated with intellectual disability and autism spectrum disorder. However, the specific functions of its multiple isoforms, generated by alternative splicing and transcription start sites, remain poorly understood. Current methods for studying SYNGAP1 functions rely on animal models, which do not fully recapitulate human neurodevelopment. This project aims to elucidate the roles of different SYNGAP1 isoforms using human cerebral organoids as an alternative to animal models. Cerebral organoids, derived from pluripotent stem cells, offer a promising 3R approach by mimicking the human brain architecture and functionality. We will employ cutting-edge techniques, including single-cell RNA sequencing, CRISPR-based gene perturbation, and BaseScope in situ hybridization to comprehensively profile SYNGAP1 isoform expression, manipulate their levels, and visualize their spatiotemporal distribution across different developmental timepoints 15, 30, 60 days, roughly equivalent to 4, 10, 18 post-conceptional weeks of human development in vivo. By developing this innovative 3D model system, we aim to uncover isoform-specific roles of SYNGAP1 in human brain development. Our approach will not only advance mechanistic understanding of SYNGAP1 biology, but also exemplify how cerebral organoids can serve as a powerful alternative to animal use.
Recommended posters
INVESTIGATING EARLY NEURODEVELOPMENTAL DISRUPTIONS IN SYNGAP1 PATIENT IPSC-DERIVED NEURAL MODELS
Montanna Waters, Lucas Teasdale, Sean Byars, Erlina Mohamed Syazwan, Nessia Eve Roseno, Cristiana Mattei, Ingrid Scheffer, Heath Pardoe, Steven Petrou, Snezana Maljevic
PATIENT-SPECIFIC NEURODEVELOPMENTAL PHENOTYPES AND PHARMACOLOGICAL STRATEGIES IN SYNGAP1 SYNDROME
Giulia Alimandi, Angela Maria Giada Giovenale, Alberto Spalice, Stefano D’Arrigo, Davide Ragozzino, Jessica Rosati, Silvia Di Angelantonio, Bernadette Basilico
INVESTIGATING GENETIC DETERMINANTS OF ANGELMAN SYNDROME IN HUMAN NEURONS
Caterina Peirone, Martina Biagioni, Federica Baronchelli, Lucia Iannotta, Raffaella Morini, Michela Matteoli, Marianna Leonzino, Matteo Fossati
DEVELOPMENT OF AN OPTICAL ACTUATOR-REPORTER TOOLSET AND MOLECULAR-COMPUTATIONAL WORKFLOW TO PHENOTYPE PATHOGENICITY OF MISSENSE VARIANTS OF THE RARE MONOGENIC DISEASE GENE SYNGAP1
Michael Courtney, Dulashini Udawatta, Li-Li Li
DISTINCT SPECTRAL, CONNECTIVITY, AND FIRING DYNAMICS AROUND SEIZURES IN RAT MODELS OF SYNGAP1 AND GRIN2B NEURODEVELOPMENTAL DISORDERS
Natalie Ling Sum Hung, Mehmet Taskiran, Katerina Hristova, Lucy Pritchard, Adrian Duszkiewicz, Alfredo Gonzalez-Sulser
DELINEATING CELL TYPE-SPECIFIC ROLES OF SETBP1 DURING NEURODEVELOPMENT USING HUMAN NEURAL ORGANOIDS AND TRANSCRIPTOMICS
Maggie Wong, Joery den Hoed, Willemijn J.J. Claassen, Veronika Bejczy, Jean Corbally, Aroa Elortza-Payros, Christan Janssen, Jill Kessen, Lukas Lütje, Letizia Vogini, Mandoh Zeijdner, Bregje W. van Bon, Simon E. Fisher